MTR 2756 a > G polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population

Lupus

Volumn 16, Issue 6, 2007, Pages 450-454

  Burzynski M ^a   Duriagin, S ^a   Mostowska, M ^a   Wudarski, M ^b   Chwalinska Sadowska H ^b   Jagodzinski P P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

MTHFD1; MTHFR; MTR; Polymorphisms; SLE

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE CYCLOHYDROLASE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FORMATE TETRAHYDROFOLATE LIGASE; METHIONINE SYNTHASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADENINE; ADULT; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GUANINE; HETEROZYGOTE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POLAND; POLYMORPHISM, GENETIC;

EID: 34547220582     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307077988     Document Type: Article

References (39)

1. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
2. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
3. Dayal AK, Kammer GM. The T cell enigma in lupus. Arthritis Rheum 1996; 39: 23-33.
4. Wilson CB, Makar KW, Perez-Melgosa M. Epigenetic regulation of T cell fate and function. J Infect Dis 2002; 185: 37-45.
5. Makers KW, Wilson CB. DNA methylation is a nonredundant repressor of the Th2 effector program. J Immunol 2004; 173: 4402-4406.
6. Fuks F, Burgers WA, Brehm A, Hughes-Davies L, Kouzarides T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet 2000; 20: 88-91.
7. Robertson KD, Uzvolgyi E, Liang G et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999; 27: 2291-2298.
8. Cantoni GL. The role of S-adenosylhomocysteine in the biological utilization of S-adenosylmethionine. Prig Clin Biol Res 1985; 198: 47-65.
9. Hoffman DR, Cornatzer WE, Duerre JA. Relationship between tissue levels of S-adenosylmethionine, S-adenylhomocysteine, and transmethylation reactions. Can J Biochem 1979; 57: 56-65.
10. Cantoni GL. S-adenosylmethionine; a new intermediate fordem enzymatically from L-methionine and adenosinetriphosphate. J Biol Chem 1953; 204: 403-416.
11. Arakawa T, Narisawa K, Tanno K, Hirooka Y, Ono T. Megaloblastic anemia and mental retardation associated with hyperfolic-acidemia: probably due to N-5-methyltetrahydrofolate transferase deficiency. Tohoku J Exp Med 1967; 93: 1-22.
12. Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 1995; 10: 111-113.
13. Hum DW, Bell AW, Rozen R, MacKenzie RE. Primary structure of a human trifunctional enzyme: isolation of a cDNA encoding methylenetetrahydrofolate- dehydrogenase, methenyltetrahydrofolatecyclohydrolase, formyltetrahydrofolate synthetase. J Biol Chem 1988; 263: 15946-15950.
14. Ballestar E, Esteller M, Richardson BC. The epigenetic face of systemic lupus erythematosus. J Immunol 2006; 176: 7143-7143.
15. Chen LH, Liu ML, Hwang HY, Chen LS, Korenberg J, Shane B. Human methionine synthase: cDNA cloning, gene localization, and expression. J Biol Chem 1997; 272: 3628-3634.
16. Paz MF, Avila S, Fraga MF et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 2002; 62: 4519-4524.
17. James SJ, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 2002; 132: 2361S-2366S.
18. Brody LC, Conley M, Cox C et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/ methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 2002; 71: 1207-1215.
19. Parle-McDermott A, Mills JL, Kirke PN et al. MTHFD1 R653Q polymorphism is a maternal genetic risk factor for severe abruptio placentae. Am J Med Genet A 2005; 132: 365-368.
20. Hol FA, van der Put NM, Geurds MP et al. Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate- cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects. Clin Genet 1998; 53: 119-125.
21. Mostowska A, Hozyasz KK, Jagodzinski PP. Maternal MTR genotype contributes to the risk of non-syndromic cleft lip and palate in the Polish population. Clin Genet 2006; 69: 512-517.
22. Doolin MT, Barbaux S, McDonnell M, Hoess K, Whitehead AS, Mitchell LE. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 2002; 71: 1222-1226.
23. Bosco P, Gueant-Rodriguez RM, Anello G et al. Methionine synthase (MTR) 2756 (A -> G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A 2003; 121: 219-224.
24. Fang JY, Xiao SD. Folic acid, polymorphism of methyl-group metabolism genes, and DNA methylation in relation to GI carcinogenesis. J Gastroenterol 2003; 9: 821-829.
25. Gemmati D, Ongaro A, Scapoli GL et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004; 5: 787-794.
26. Skibola CF, Forrest MS, Coppede F et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004; 7: 2155-2162.
27. Harmon DL, Shields DC, Woodside JV et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999; 4: 298-309.
28. Tsai MY, Bignell M, Yang F, Welge BG, Graham KJ, Hanson NQ. Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels. Atherosclerosis 2000; 1: 131-137.
29. Chen J, Stampfer MJ, Ma J et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 2001; 3: 667-672.
30. Silaste ML, Rantala M, Sampi M, Alfthan G, Aro A, Kesaniemi YA. Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. J Nutr 2001; 10: 2643-2647.
31. Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001; 5532: 1068-1070.
32. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol 2004; 22: 4632-4642.
33. Kang S, Kim JW, Kang GH et al. Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol 2005; 1: 173-180.
34. Richardson BC, Strahler JR, Pivirotto TS et al. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum 1992; 35: 647-662.
35. Sano H, Takai O, Harata N, Yoshinaga K, Kodama-Kamada I, Sasaki T. Binding properties of human anti-DNA antibodies to cloned human DNA fragments. Scand J Immunol 1989; 30: 51-63.
36. YU D, Zhu FG, Bhagat L et al. Potent CpG oligonucleotides containing phosphodiester linkages: in vitro and in vivo immunostimulatory properties. Biochem Biophys Res Commun 2002; 297: 83-90.
37. Wong M, Tsao BP. Current topics in human SLE genetics. Springer Semin Immunopathol Epub 2006; 28: 97-107.
38. Meyer O, Hauptmann G, Tappeiner G, Ochs HD, Mascart-Lemone F. Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies. Clin Exp Immunol 1985; 62: 678-684.
39. Tsao BP, Cantor R, Kalunian KC et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997; 99: 725-731.